GALECTIN THERAPEUTICS INC.

Consensus Galectin Therapeutics Inc.

Stocks

GALT

US3632252025

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-09-11 EDT			5-day change	1st Jan Change
3.910 ^USD	+0.26%		-15.18%	-6.01%

08-14	Galectin Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-29	Galectin Therapeutics Inc.(NasdaqCM:GALT) added to Russell Small Cap Comp Growth Benchmark	CI

Evolution of the Average Target: Galectin Therapeutics Inc.

Evolution of the Target Price: Galectin Therapeutics Inc.

Changes in Analyst Recommendations: Galectin Therapeutics Inc.

356f0167b58451af7fa570d382.mR8qW-T8Zc9NBRDaQy26DUOrgPoHN1VRzLlC4PQoS7k.tFxhP5CxJ_kZPCORGR3DdDrt1MNefxgEi842qY1rOPygUgdvraNctjlBUQ~586d54e6f253b1d5e8d0e519d955672e

Analysts' recommendations: Galectin Therapeutics Inc.

24-12-27	HC Wainwright Downgrades Galectin Therapeutics to Neutral From Buy	MT
22-05-17	HC Wainwright Adjusts Price Target on Galectin Therapeutics to $11 From $14, Reiterates Buy Rating	MT
21-04-16	Galectin Therapeutics : HC Wainwright Adjusts Price Target on Galectin Therapeutics to $14 From $12, Maintains Buy Rating	MT

More recommendations

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	GALECTIN THERAPEUTICS INC.			-	-	+181.33%
	LONZA GROUP AG					+29.55%
	REVOLUTION MEDICINES, INC.					+23.28%
	IQVIA HOLDINGS INC.					+5.54%
	BEONE MEDICINES AG					+24.8%
	CELLTRION, INC.					+50.52%
	ASCENDIS PHARMA A/S					+19.38%
	MEDPACE HOLDINGS, INC.					-0.97%
	EUROFINS SCIENTIFIC SE					+2.18%
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.					+1.5%
	Average					+33.71%
	Weighted average by Cap.					+21.23%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

3.910USD

Average target price

11.00USD

Spread / Average Target

+181.33%

High Price Target

11.00USD

Spread / Highest target

+181.33%

Low Price Target

11.00USD

Spread / Lowest Target

+181.33%

Analyst Consensus Detail

Consensus revision (last 18 months)

Stock Market
Stocks
GALT Stock
Consensus Galectin Therapeutics Inc.

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!